Copyright: ©Author(s) 2026.
World J Cardiol. May 26, 2026; 18(5): 119100
Published online May 26, 2026. doi: 10.4330/wjc.v18.i5.119100
Published online May 26, 2026. doi: 10.4330/wjc.v18.i5.119100
Table 2 Baseline characteristics of included population, mean ± SD/n (%)
| Ref. | Age | Male gender | Hypertension | Diabetes mellitus | ||||
| Study group (years) | Control group (years) | Study group | Control group | Study group | Control group | Study group | Control group | |
| Vaduganathan et al[10], 2016 | NA | NA | NA | NA | NA | NA | NA | NA |
| Wei et al[9], 2016 | 59.32 ± 9.14 | 58.47 ± 10 | 69 (56.1) | 48 (57.1) | 502 (50.4) | 496 (49.0) | ||
| Yasu et al[15], 2010 | 69.9 ± 9.6 | 67.4 ± 10.1 | 69 (67.0) | 144 (72.4) | 66 (64.1) | 129 (64.8) | 70 (68.0) | 115 (57.8) |
| Kim et al[13], 2024 | 65.1 ± 11.2 | 65.6 ± 11.2 | 754 (66.5) | 745 (65.8) | 677 (59.8) | 705 (62.2) | 762 (65.8) | 128 (72.5) |
| Jensen et al[12], 2017 | 64.7 ± 10.2 | 64.8 ± 10.6 | 729 (73.1) | 758 (74.9) | 535 (53.7) | 546 (54.0) | 113 (11.3) | 103 (10.2) |
| Rossini et al[14], 2011 | 64 ± 11 | 63 ± 11 | 875 (75.6) | 138 (81.2) | 736 (63.6) | 111 (65.2) | 14338 (40.3) | 13975 (39.3) |
| Ren et al[11], 2011 | 62.08 ± 10.62 | 61.84 ± 11.21 | 62 | 63 | 415 (83) | 419 (83.8) | ||
| Aihara et al[16], 2012 | 68 ± 11 | 69 ± 10 | 363 (72.6) | 379 (75.8) | 356 (71.2) | 345 (69.0) | 205 (61.9) | 579 (61.7) |
| Chandrasekhar et al[17], 2017 | 65.4 ± 11.1 | 64.1 ± 11.4 | 2686 (75.2) | 738 (69.5) | 847 (79.8) | 2873 (80.4) | 349 (32.9) | 1171 (32.8) |
- Citation: Sohail R, Khan Z, Shah HH, Khattak R, Khan A, Chaudhry S, Khan U, Mansoor H, Namal F, Orciuolo J, Desai S, Singh M. Cardiovascular safety of proton pump inhibitors in post-percutaneous coronary intervention patients receiving dual antiplatelet therapy: A meta-analysis. World J Cardiol 2026; 18(5): 119100
- URL: https://www.wjgnet.com/1949-8462/full/v18/i5/119100.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i5.119100